Evidence map›Paper›PMID 41369769›Full record

ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2026

Biconcave vertebral fractures as a possible distinctive feature of indolent systemic mastocytosis compared with primary osteoporosis.

Gaetano Paride Arcidiacono, Marco Onofrio Torres, Francesca Zanchetta, Sofia Testoni, Giovanni Tripepi, Alberta Cecchinato, Martin Diogo, Mor Peleg Falb, Francesca Guidolin, Irene Bertozzi and 13 more

Abstract readComparative Study
In one paragraph

Article in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Gaetano Paride Arcidiacono *Department of Medicine, University of Padova, Padua, Italy.ORCID http://orcid.org/0000-0003-0409-4449
Marco Onofrio Torres *Department of Medicine, University of Padova, Padua, Italy.ORCID http://orcid.org/0009-0004-1426-1452
Francesca ZanchettaDepartment of Medicine, University of Padova, Padua, Italy.
Sofia TestoniRheumatology Unit, University of Modena and Reggio Emilia, Modena, Italy.ORCID http://orcid.org/0000-0001-5840-7290
Giovanni TripepiNational Research Council (CNR), Institute of Clinical Physiology (IFC), Clinical Epidemiology of Renal Diseases and Hypertension, Ospedali Riuniti, Reggio Calabria, Italy.ORCID http://orcid.org/0000-0002-3580-4602
Alberta CecchinatoDepartment of Medicine, University of Padova, Padua, Italy.
Martin DiogoDepartment of Medicine, University of Padova, Padua, Italy.
Mor Peleg FalbDepartment of Medicine, University of Padova, Padua, Italy.ORCID http://orcid.org/0009-0006-9413-3710
Francesca GuidolinDepartment of Medicine, University of Padova, Padua, Italy.
Irene BertozziDepartment of Medicine, University of Padova, Padua, Italy.ORCID http://orcid.org/0000-0003-2888-9596
Marco PizziDepartment of Medicine, University of Padova, Padua, Italy.ORCID http://orcid.org/0000-0003-4006-7317
Mauro CancianUOSD Allergologia, Azienda Ospedale-Università Padova, Padua, Italy.ORCID http://orcid.org/0000-0003-2246-9144
Riccardo SenterUOSD Allergologia, Azienda Ospedale-Università Padova, Padua, Italy.ORCID http://orcid.org/0000-0001-7987-8235
Ilaria GianeselloHematology and Clinical Immunology Unit, Azienda Ospedale-Università Padova, Padua, Italy.
Francesca CaroppoDermatology Unit, Azienda Ospedale-Università Padova, Padua, Italy.ORCID http://orcid.org/0000-0003-3583-0816
Ilaria TanasiHematology Unit, Department of Medicine, Azienda Ospedaliera Universitaria Integrata Di Verona, Verona, Italy.ORCID http://orcid.org/0000-0001-8177-374X
Roberta ZanottiHematology Unit, Department of Medicine, Azienda Ospedaliera Universitaria Integrata Di Verona, Verona, Italy.ORCID http://orcid.org/0000-0003-2871-9730
Lorenza BellettiRheumatology Unit, University of Modena and Reggio Emilia, Modena, Italy.
Maria FusaroDepartment of Medicine, University of Padova, Padua, Italy.ORCID http://orcid.org/0000-0001-9478-4851
Elena CampelloDepartment of Medicine, University of Padova, Padua, Italy.ORCID http://orcid.org/0000-0002-0377-3741
Stefania SellaDepartment of Medicine, University of Padova, Padua, Italy. stefania.sella@unipd.it.ORCID http://orcid.org/0000-0002-8645-4067
Paolo SimioniDepartment of Medicine, University of Padova, Padua, Italy.ORCID http://orcid.org/0000-0002-6744-383X
Sandro GianniniDepartment of Medicine, University of Padova, Padua, Italy.ORCID http://orcid.org/0000-0003-0796-9749

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Indolent systemic mastocytosis (ISM) is a rare cause of skeletal fragility. In this study, patients with ISM showed a markedly higher prevalence of biconcave vertebral fractures compared with primary osteoporosis. Assessing fracture morphology may aid in differentiating ISM, reducing diagnostic delay, and guiding appropriate management. PURPOSE: Indolent systemic mastocytosis (ISM) is a rare disorder frequently associated with bone fragility and vertebral fractures (VFx). While the morphology of VFx has been studied in other metabolic bone diseases (e.g., osteomalacia), its role in ISM remains unclear. We aimed to evaluate the prevalence of specific VFx morphologies in ISM and assess their potential diagnostic value compared with primary osteoporosis (OP).

methodsWe retrospectively enrolled adults with ISM and VFx, diagnosed according to WHO and ICC criteria. To increase statistical power, each ISM case was compared with two controls with OP. Clinical, densitometric, and laboratory data were collected. VFx were assessed on lateral spine X-rays (T4-L4) using Genant's criteria and categorized as wedge or biconcave.

resultsSixty-six patients were included: 22 with ISM and 44 with OP. ISM patients were younger (68 ± 8 vs. 77 ± 7 years, p < 0.001) and more frequently male (32% vs. 7%, p = 0.043). ISM patients had more VFx (median 4 vs. 3, p = 0.039) and a higher proportion of biconcave VFx (80% vs. 22%, p < 0.001). ROC analysis showed high discriminatory power for the number and proportion of biconcave VFx (AUC 0.878 and AUC 0.919, respectively) in distinguishing ISM from OP, with optimal cut-offs of > 2 biconcave VFx or > 50% of total VFx. These findings remained consistent after adjustment for age and sex.

conclusionMultiple biconcave VFx are significantly associated with ISM and may help differentiate it from primary OP. Assessment of fracture morphology could reduce diagnostic delay and guide appropriate management in patients with vertebral fragility fractures.

Indexed as

Mastocytosis, SystemicOsteoporosisOsteoporotic FracturesSpinal FracturesAbsorptiometry, PhotonAdultAgedAged, 80 and overBone DensityDiagnosis, DifferentialFemaleHumansLumbar VertebraeMaleMiddle AgedRetrospective StudiesBone fragilityMastocytosisMorphometric analysisOsteoporosisRare diseasesVertebral fractures

Identifiers

PMID41369769
PMCPMC12956990

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.